Search Results
Nov 14, 2025, 08:00 ET HI-CHEW® and LONELY GHOST Team Up to Celebrate the Holidays in Sweet Style
currently offered in sticks, peg bags, and stand-up pouches. The HI-CHEW® sticks come in a variety of flavors including Strawberry, Green Apple, Mango, Grape, Banana, Kiwi, Açaí, Sweet & Sour Watermelon, and new Blue Raspberry. HI-CHEW® also offers peg bags in the following flavors:
More news about: HI-CHEW
Nov 13, 2025, 13:01 ET American Waterways Operators, National Safe Boating Council Launch Video on Safe Boating Near Commercial Vessels
nation's commerce, and this jointly-produced video with the NSBC will be an important tool in that effort." Peg Phillips, executive director of the National Safe Boating Council, commented: "Our partnership with AWO plays a vital role in advancing education
More news about: American Waterways Operators
Nov 13, 2025, 09:06 ET Neil Lane is a Proud Participant in the Finale of "The Golden Bachelor"
perfect teammate he's been waiting for in his golden years. In the final episode of the season Mel selects a handmade ring for Peg. There's no better way to celebrate a Golden Bachelor couple than with an 18 kt, hand crafted golden ring, centrally set with a cushion cut diamond and
More news about: Neil Lane Couture
Nov 11, 2025, 08:58 ET iLeukon Therapeutics Presents Phase I Data for ILKN421H at SITC 2025
enables robust CD8+ T/NK cell proliferation with 1/100 of systemic IL-2v exposure compared with other protein based counterparts like PEG-IL-2v. Favorable Safety and TolerabilityAcross 45 patients with advanced
More news about: iLeukon Therapeutics
Nov 10, 2025, 08:30 ET Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B
in BRII-179 anti-HBs responders treated with elebsiran plus pegylated interferon alfa (PEG-IFNα) Data suggest the potential to shorten PEG-IFNα treatment duration for BRII-179 anti-HBs responders showing faster and greater HBsAg
More news about: Brii Biosciences Limited
Nov 10, 2025, 08:30 ET 騰盛博藥在2025年AASLD大會上發佈ENSURE II期研究最新突破性數據，進一步強調BRII-179作為慢乙肝治癒性療法的潛力
elebsiran 聯合聚乙二醇干擾素 α （ PEG-IFNα ）治療的 BRII-179 抗 -HBs
More news about: 騰盛博藥生物科技有限公司
Nov 07, 2025, 15:16 ET The Party Goddess! Celebrates "Golden Bachelor" Finale with Exclusive Watch Party Guide & Podcast Drop
November 12 at 8 PM ET/ 5 PM PT. "Everyone deserves a little sparkle in their love story," says Majcher. "Whether you're team Peg or team Cindy, this is your excuse to throw a party that feels as warm as the golden hour itself." Inside
More news about: The Party Goddess!
Nov 07, 2025, 09:00 ET Marengo Late-Breaking Oral Presentation Highlights Single-Agent, Pan Tumor Activity of Invikafusp Alfa Across PD-1-Resistant Cancers in Phase 2 Clinical Trial at SITC 2025
[email protected]. Marengo Contacts: MediaPeg Rusconi I [email protected]
More news about: Marengo Therapeutics
Nov 07, 2025, 08:30 ET Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine
was observed in 4 of 19 participants (21.1%) in Cohort 2 (elebsiran 200 mg + PEG-IFNα) and 6 of 18 participants (33.3%) in Cohort 3 (elebsiran 100 mg + PEG-IFNα), compared to 1 of 18 participant (5.6%) in Cohort 1 (PEG-IFNα monotherapy). Cohort 4:
More news about: Brii Biosciences Limited
Nov 07, 2025, 08:30 ET 騰盛博藥宣佈在《自然-醫學》發表ENSURE II期研究結果
隊列1-3：在治療結束後24周，在隊列2（elebsiran 200mg + PEG-IFNα）的19名參與者中4例（21.1%）實現了HBsAg清除；在隊列3（elebsiran 100 mg + PEG-IFNα）的18 名參與者中6例（33.3%）實現了HBsAg清除。相比之下，隊列1（PEG-IFNα單藥）18名參與者中僅有1例（5.6%）實現了HBsAg清除。 隊列4：在治療結束後24周，參與者中BRII-179抗-HBs應答者的應答率為41.1%（19名參與者中8名），顯著高於無應答者（12名參與者中1名，8.3%）。所有
More news about: 騰盛博藥生物科技有限公司
Nov 05, 2025, 04:00 ET Crossover Markets Announces Record Results
routing, and an architectural framework to perform system releases intra week without disruption. Participants now have access to post-only, iceberg, and peg-to-mid order types, as well as the capacity for bespoke order types based on client demand. The system upgrade comes at a time when Crossover is expanding
More news about: Crossover Markets
Nov 05, 2025, 04:00 ET Crossover Markets Announces Record Results
routing, and an architectural framework to perform system releases intra week without disruption. Participants now have access to post-only, iceberg, and peg-to-mid order types, as well as the capacity for bespoke order types based on client demand. The system upgrade comes at a time when Crossover is expanding
More news about: Crossover Markets
Nov 04, 2025, 07:00 ET Magnet Biomedicine Appoints Bharat Reddy, Ph.D., as Chief Business Officer
X, formerly known as Twitter. Media ContactPeg RusconiVerge Scientific [email protected]
More news about: Magnet Biomedicine
Nov 03, 2025, 10:01 ET Personal Care Emulsifiers Market to Reach $2.8 Billion, Globally, by 2034 at 6.5% CAGR: Allied Market Research
China remains one of the top exporters of Personal Care Emulsifiers, particularly supplying non-ionic emulsifiers such as glyceryl stearate and PEG derivatives. Recent shipping records from 2023 indicate consistent exports to countries like Vietnam, Indonesia, and Brazil, where cosmetic production
More news about: Allied Market Research
Nov 03, 2025, 07:30 ET PSEG ANNOUNCES THIRD QUARTER 2025 RESULTS
NEWARK, N.J., Nov. 3, 2025 /PRNewswire/ -- Public Service Enterprise Group (NYSE: PEG) reported the following results for the third quarter and nine months ended September 30, 2025:
More news about: Public Service Enterprise Group
Oct 31, 2025, 09:08 ET Stablecoins New Era Begins: Inside the Next Wave of Institutional Adoption and Infrastructure Competition
yield-bearing stablecoins are rapidly gaining market share. The study identifies a structural evolution from single-purpose payment tools to a "Three-in-One Model"—Peg + Yield + Application—that extends stablecoin utility into yield generation, real-world asset integration, and enterprise use cases
More news about: Alchemy Pay
Oct 31, 2025, 07:00 ET Marengo to Present Late-Breaking Clinical Oral Abstract at SITC 2025 Highlighting Initial Monotherapy Activity of Invikafusp Alfa in Tissue-Agnostic, TMB-High Advanced Cancers
[email protected]. Marengo Contacts: MediaPeg Rusconi I [email protected]
More news about: Marengo Therapeutics
Oct 30, 2025, 11:15 ET The VerifiedX Foundation Unveils "Butterfly" The World's First Self-Custodial Social P2P Payment and Commerce Platform for Everyday Users
(VFX) can be accessed directly in-wallet, and enables minting of Verified Bitcoin Tokens (vBTC) with a 1:1 evergreen self-custodial peg coupled with smart contract utility and full asset recovery features for funds. Providing robust in-wallet and self-custodial
More news about: VerifiedX.io
Oct 30, 2025, 11:15 ET The VerifiedX Foundation Unveils "Butterfly" The World's First Self-Custodial Social P2P Payment and Commerce Platform for Everyday Users
directly in-wallet, and enables minting of Verified Bitcoin Tokens (vBTC) with a 1:1 evergreen self-custodial peg coupled with smart contract utility and full asset recovery features for funds. Providing robust in-wallet and self-custodial
More news about: VerifiedX.io
Oct 29, 2025, 09:00 ET FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria
of PALYNZIQ in adult patients with PKU, two patients receiving concomitant injections of medroxyprogesterone acetate suspension (a formulation containing PEG 3350) experienced a hypersensitivity reaction. One of the two patients experienced anaphylaxis The clinical effects of concomitant
More news about: BioMarin Pharmaceutical Inc.
Oct 27, 2025, 11:00 ET Qodo Named to TechCrunch AI Disruptors 60 List
Founded in 2018, Qodo has raised $50 million in funding, with backing from notable investors including TLV Partners, Vine Ventures, Susa Ventures, Square Peg, and angels including executives from OpenAI, Shopify, and Snyk. For more information, visit www.qodo.ai.
More news about: Qodo
Oct 27, 2025, 06:00 ET Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
X. Media: DeerfieldPeg Rusconi [email protected]
More news about: Hemab Therapeutics
Oct 20, 2025, 10:00 ET Fred Rogers Productions Launches Many Ways to Show You Care
generations of children and families with his timeless wisdom. The company's highly rated children's series, including Daniel Tiger's Neighborhood, Peg + Cat, Odd Squad, and Through the Woods, have earned 31 Emmy® Awards among other important honors. The company's
More news about: Fred Rogers Production
Oct 17, 2025, 08:00 ET Marengo Presents Initial Phase 2 Results Demonstrating Broad Single-Agent Activity of Invikafusp Alfa Across Multiple PD-1-Refractory or -Resistant Solid Tumors as a Late-Breaking Oral Presentation at ESMO 2025
[email protected]. Marengo Contacts: MediaPeg Rusconi I [email protected]
More news about: Marengo Therapeutics
Oct 16, 2025, 08:45 ET Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis
outcomes were observed: Significant efficacy: All five patients demonstrated significant improvements in EDSS scores, Nine-Hole Peg Test (9-HPT), and Timed 25-Foot Walk (T25FW) tests. Complete disappearance of cerebrospinal fluid oligoclonal bands (OCBs) and significant decrease in
More news about: IASO Bio